Corporate
Profile
Failed to register as Favorite Page
Failed to cancel as Favorite Page
This page is already registered as a Favorite Page
You can't add your company to your favorites.
Latest update： 27/04/2017 14:11:18
Bonac Co., Ltd.
We have a domestic and international presence in nucleic acid medicine, an area of next-generation pharmaceuticals.
We conduct R&D in nucleic acid medicine, which is drawing attention as a fertile area for next-generation pharmaceuticals. Nucleic acid pharmaceuticals use biomolecular nucleic acid composed of DNA and ribonucleic acid (RNA). Working in this field, we discovered Bonac nucleic acid, a nucleic acid molecule that is structurally different from conventional siRNA. We have established the foundational technologies for Bonac nucleic acid and obtained patents in Japan, the United States, and Europe. As we work toward commercializing Bonac nucleic acid, our presence has risen both in Japan and internationally. Our company is also involved in the business of consulting on nucleic acid and licensing patents.
Overview
| Corporate name | Bonac Co., Ltd. |
|---|---|
| Representative | Hirotake Hayashi |
| Corporate website | http://www.bonac.co.jp |
| Capital | 174,480,000(JPY) |
| Number of Employees | 26 |
| Established date | 2010 |
| Head office: Country | Japan |
| Head office: Address | Fukuoka Prefecture Biofactory, 1488-4, Aikawachou, Kurume, Fukuoka, 839-0861 |
| Industry | Wholesale(1) |
| Main phone number | +81-942326700 |
